论文部分内容阅读
关于增殖性糖尿病性视网膜病变的治疗,全网膜光凝固术的治疗效果已被公认,但对于因该症而并发玻璃体出血,视网膜前出血或牵引性视网膜剥离的病例,单作光凝固治疗不能达到治疗目的,必须有赖于作玻璃体手术。历来对于增殖性糖尿病性视网膜病变的玻璃本手术的适应症是:①未能被吸收的玻璃体出血,②牵涉到黄斑部的牵引性视。③牵引性裂孔所致的视网膜剥离④黄斑前纤维性增殖并引起高度视力障碍者,等等。但是,按以上手术适应症来说,增殖性糖尿病
For the treatment of proliferative diabetic retinopathy, the therapeutic effect of total retinal photocoagulation has been recognized, but for the case of complications associated with vitreous hemorrhage, retinal hemorrhage or traction retinal detachment cases, single photocoagulation treatment can not To achieve the purpose of treatment, must rely on vitrectomy. Indications for proliferative diabetic retinopathy of the glass of the operation indications are: ① failed to be absorbed vitreous hemorrhage, ② involving the traction of the macular degeneration. ③ retinal detachment due to traumatic retinal detachment ④ macular degeneration and fibrosis caused by a high degree of visual impairment, and so on. However, according to the above indications of surgery, proliferative diabetes